Serotonergic antagonists and vascular disease
- PMID: 2285653
- DOI: 10.1007/BF00053420
Serotonergic antagonists and vascular disease
Abstract
5-Hydroxytryptamine (serotonin) can evoke both contraction and relaxation of vascular smooth muscle. In disease, the constrictor component of the response to the monoamine appears to dominate. 5HT2-serotonergic antagonists favor dilatation, not only because they block the activating effect of serotonin on vascular smooth muscle, but also because they unmask the (endothelium-dependent) relaxation to the monoamine and brake the amplifying effect that it exerts on platelet aggregation. These properties of serotonergic antagonists help to explain their protective effects in vascular disease.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical